Camron D. Bryant, Ph.D.

2012-11-08 13.08.21Assistant Professor of Pharmacology and Psychiatry
Department of Pharmacology

Ph.D., University of California, Los Angeles

Laboratory: To view Bryant Laboratory page click Laboratory of Addiction Genetics

Research Interests

Dr. Bryant is the Director of the Laboratory of Addiction Genetics.  Dr. Bryant’s research program is focused on determining the genetic basis of behavioral and molecular traits relevant to substance dependence in mice.  The ultimate goal is to improve our understanding of the neurobiological mechanisms of addiction and to translate these findings toward treatment and prevention strategies in humans.  A current focus is to determine the genetic basis of the rewarding properties of opioids in mice by combining quantitative trait locus (QTL) analysis of behavior and gene expression in genetic reference populations that yield high resolution QTLs.  This multi-pronged approach to gene mapping will accelerate the nomination of candidate genes for validation via direct gene targeting.  A separate focus with regard to functional characterization of candidate genes is the dissection of the hypothesized opposing roles of casein kinase-1 (CK-1) isoforms in regulating dopaminergic signaling and the motivational properties of drugs of abuse.  Last, Dr. Bryant has a longstanding interest in deciphering the neurobiological basis of the “placebo effect”, a phenomenon that has been hypothesized to be mediated by the reward expectation.  He plans to develop and apply a forward genetic analysis toward Pavlovian conditioning mouse models across a variety of conditions that are notoriously sensitive to the placebo effect, including pain, anxiety, depression, and Parkinson’s Disease.